FDA Investigator Haijing Hu
Haijing Hu has conducted inspections on 5 sites in 1 countries as of 08 Aug 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
08 Aug 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Haijing Hu:
Anthony W Lee,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Bonita S Chester,
Brooke K Higgins,
Camerson E Moore,
Carol S Davis,
Claire M Minden,
Elizabeth D Connell,
Jessica L Pressley,
Latorie S Jones,
Linda F Murphy,
Lisa R Jennings,
Lisa R Whitt,
Lizaida E Rodriguez,
Lourdes Andujar,
Marc Balzarini,
Massoud Motamed,
Matthew B Thomaston,
Meredith M Cobb,
Rachel C Harrington,
Sandra Carpio,
Sara Rothman,
Scott T Ballard,
Sharon Giamberini,
Stacie A Woods,
Torrance J Slayton
Haijing Hu's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2017 | FDA 483 | Cantrell Drug Company - Form 483, 2017-06-29 |
April, 2016 | FDA 483 | RX South DBA RX3 Compounding Pharmacy LLC - Form 483, 2016-04-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more